Identification of a novel subtype of SPP1 + macrophages expressing SIRPα: implications for tumor immune evasion and treatment response prediction
2024

New Subtype of Macrophages Linked to Tumor Response

Sample size: 240 publication 10 minutes Evidence: high

Author Information

Author(s): Chen Kun, Li Yida, Ni Jianjiao, Yang Xi, Zhou Yue, Pang Yechun, Ye Ruiting, Chen Hongru, Yu Silai, Wang Peng, Zhu Zhengfei

Primary Institution: Fudan University Shanghai Cancer Center

Hypothesis

The study investigates the role of a novel subtype of SPP1+ macrophages expressing SIRPα in tumor immune evasion and treatment response prediction.

Conclusion

A novel subtype of SPP1+ macrophages expressing SIRPα was identified, and their abundance predicted patients' response to PD-1/PD-L1 inhibitors.

Supporting Evidence

  • SPP1+ macrophages showed high phagocytic activity and were enriched in tumor tissues.
  • High abundance of SPP1+ SIRPα+ macrophages correlated with better responses to PD-1/PD-L1 inhibitors.
  • SPP1+ SIRPα+ macrophages were found closer to tumor cells and CD8+ T cells, indicating their active role in the tumor microenvironment.

Takeaway

Scientists found a new type of immune cell that helps tumors hide and can predict how well patients will respond to certain cancer treatments.

Methodology

The study used single-cell RNA sequencing and multiplexed immunohistochemistry to analyze macrophages in various cancer types.

Participant Demographics

240 treatment-naïve, histologically confirmed ESCC patients.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s40164-024-00587-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication